Far Infrared Irradiation for Management and Treating of Parkinson's Disease (PD)
Far Infrared Irradiation for Management and Treating of Parkinson's Disease (PD)
Parkinson's disease (PD) is a degenerative disorder of the central nervous system that often
 impairs the sufferer's motor skills and speech. This study will investigate the use of far
 infrared radiation to manage, control and treat PD.
Parkinson's disease belongs to a group of conditions called movement disorders. It is
 characterized by muscle rigidity, tremor, a slowing of physical movement and, in extreme
 cases, a loss of physical movement. The primary symptoms are the results of decreased
 stimulation of the motor cortex by the basal ganglia, normally caused by the insufficient
 formation and action of dopamine, which is produced in the dopaminergic neurons of the brain.
 PD is both chronic and progressive.

 Observations from our research studies indicate that, far infrared rays provide energy to the
 body, improve the autonomic functions of the nervous system, restore the functions of the
 endocrine system, strengthen the immune system, improve blood circulation and increase the
 level of oxygen in the cells and promote the regeneration of muscle cells, nerves and brain
 cells.

 It is hereby postulated that irradiation using far infrared, with wavelength between 5 to 20
 microns, of the central nervous system, the endocrine system and the whole body could
 prevent, control, manage or possibly lead to complete rehabilitation of people who have PD.
Inclusion Criteria:

 -  People with Parkinson's Disease

 Exclusion Criteria:

 -  None